High Vista Strategies LLC Agenus Inc Transaction History

High Vista Strategies LLC

  • $255 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.92 - $5.74 $66,868 - $131,446
-22,900 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$2.98 - $5.2 $19,966 - $34,840
6,700 Added 41.36%
22,900 $92,000
Q4 2019

Feb 14, 2020
SELL
$2.41 - $4.4 $11,086 - $20,240
-4,600 Reduced 22.12%
16,200 $66,000
Q3 2019

Nov 14, 2019
BUY
$2.17 - $3.14 $45,136 - $65,312
20,800 New
20,800 $54,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email